Psychedelics closer to commercialization; Compass far and away the leader
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Analyst https://seekingalpha.com/author/alexander-carchidi?source=ie_podcast:psychedelics_closer_to_commercialization_compass_leader discusses positive news coming out of psychedelic space (1:00). Recent earnings show companies moving closer to commercialization (3:35). https://seekingalpha.com/symbol/CYBN?source=ie_podcast:psychedelics_closer_to_commercialization_compass_leader and Atai developments; clinical studies and regulatory relief (5:25)....
mostra másShow Notes:
Psychedelic therapy: FDA panel to review first ever MDMA-assisted PTSD treatment
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
COMPASS Pathways Q1 2024 Earnings Call Transcript
Episode transcripts
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Register for Seeking Alpha's Investing Summit (with your podcast discount code!)
Información
Autor | Seeking Alpha |
Organización | Seeking Alpha |
Página web | seekingalpha.com |
Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company